| AMD3100 is a CXCR7 ligand with allosteric agonist properties I Kalatskaya, YA Berchiche, S Gravel, BJ Limberg, JS Rosenbaum, ... Molecular pharmacology 75 (5), 1240-1247, 2009 | 427 | 2009 |
| Bioluminescence resonance energy transfer reveals ligand-induced conformational changes in CXCR4 homo-and heterodimers Y Percherancier, YA Berchiche, I Slight, R Volkmer-Engert, H Tamamura, ... Journal of Biological Chemistry 280 (11), 9895-9903, 2005 | 358 | 2005 |
| Decreasing the frameshift efficiency translates into an equivalent reduction of the replication of the human immunodeficiency virus type 1 D Dulude, YA Berchiche, K Gendron, L Brakier-Gingras, N Heveker Virology 345 (1), 127-136, 2006 | 126 | 2006 |
| The peptidomimetic CXCR4 antagonist TC14012 recruits β-arrestin to CXCR7: Roles of receptor domains S Gravel, C Malouf, PE Boulais, YA Berchiche, S Oishi, N Fujii, R Leduc, ... Journal of Biological Chemistry 285 (49), 37939-37943, 2010 | 118 | 2010 |
| CXC chemokine receptor 3 alternative splice variants selectively activate different signaling pathways YA Berchiche, TP Sakmar Molecular pharmacology 90 (4), 483-495, 2016 | 116 | 2016 |
| Different effects of the different natural CC chemokine receptor 2b ligands on β-arrestin recruitment, Gαi signaling, and receptor internalization YA Berchiche, S Gravel, ME Pelletier, G St-Onge, N Heveker Molecular pharmacology 79 (3), 488-498, 2011 | 85 | 2011 |
| Direct assessment of CXCR4 mutant conformations reveals complex link between receptor structure and Gαi activation YA Berchiche, KY Chow, B Lagane, M Leduc, Y Percherancier, N Fujii, ... Journal of Biological Chemistry 282 (8), 5111-5115, 2007 | 69 | 2007 |
| An engineered GM-CSF-CCL2 fusokine is a potent inhibitor of CCR2-driven inflammation as demonstrated in a murine model of inflammatory arthritis M Rafei, YA Berchiche, E Birman, MN Boivin, YK Young, JH Wu, ... The Journal of Immunology 183 (3), 1759-1766, 2009 | 56 | 2009 |
| G protein subtype–specific signaling bias in a series of CCR5 chemokine analogs E Lorenzen, E Ceraudo, YA Berchiche, CA Rico, A Fürstenberg, ... Science signaling 11 (552), eaao6152, 2018 | 50 | 2018 |
| Epitranscriptomic profiling across cell types reveals associations between APOBEC1-mediated RNA editing, gene expression outcomes, and cellular function V Rayon-Estrada, D Harjanto, CE Hamilton, YA Berchiche, EC Gantman, ... Proceedings of the National Academy of Sciences 114 (50), 13296-13301, 2017 | 50 | 2017 |
| Germline mutations in a G protein identify signaling cross-talk in T cells H Ham, H Jing, IT Lamborn, MM Kober, A Koval, YA Berchiche, ... Science 385 (6715), eadd8947, 2024 | 20 | 2024 |
| High-affinity binding of chemokine analogs that display ligand bias at the HIV-1 coreceptor CCR5 CA Rico, YA Berchiche, M Horioka, JC Peeler, E Lorenzen, H Tian, ... Biophysical journal 117 (5), 903-919, 2019 | 16 | 2019 |
| CXCR4, un récepteur de chimiokine aux multiples talents SF Desjardins, YA Berchiche, E Haddad, N Heveker médecine/sciences 23 (11), 980-984, 2007 | 7 | 2007 |
| Étude de la relation entre les conformations et la signalisation des 7TMRs YA Berchiche | 1 | 2010 |
| Multiple talents of the chemokine receptor-CXCR4 SF Desjardins, YA Berchiche, E Haddad, N Heveker Medecine Sciences: M/S 23 (11), 980-984, 2007 | 1 | 2007 |
| Investigation of G protein‐coupled receptor kinase 2 (GRK2) regulation of D2 dopamine receptor signaling: effects of GRK2 functional domains and pharmacologic … KA Schardien, MS Soto, L Inbody, Y Berchiche, JH Kehrl, C Bradfield, ... The FASEB Journal 34 (S1), 1-1, 2020 | | 2020 |
| Dominant-activating Gαi2 mutations cause human immunodeficiency and autoimmunity by causing defective leukocyte migration and altered T cell activation H Ham, I Lamborn, Y Zhang, Y Berchiche, A Koval, H Jing, JN Mandl, ... The Journal of Immunology 198 (Supplement_1), 59.16-59.16, 2017 | | 2017 |
| Direct assessment of CXCR4 mutant conformations reveals complex link between receptor structure and G i activation. YA Berchiche, KY Chow, B Lagane, M Leduc, Y Percherancier, N Fujii, ... THE JOURNAL OF BIOLOGICAL CHEMISTRY 286 (33), 29440, 2011 | | 2011 |
| An Engineered GM-CSF-CCL2 Fusokine Is N Heveker, J Galipeau, MN Boivin, YK Young, JH Wu, M Rafei, ... | | 2009 |
| 146 A GMCSF and CCL2 fusion chimera induces apoptosis in CCR2 expressing lymphomyeloid cells and promotes xenotolerance M Rafei, Y Berchiche, JH Wu, E Birman, N Heveker, J Galipeau Cytokine 43 (3), 270, 2008 | | 2008 |
Thomas P. SakmarRichard M. & Isabel P. Furlaud Professor, Rockefeller UniversityVerified email at rockefeller.edu
